Cita APA

Sanchez Mauriño, P., Serrano Domingo, J. J., García Galindo , R., Sequero-Lopez, S., Gutierrez Sanz, L., SORIA RIVAS, A., & MUÑOZ COUSELO, E. (2025). Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: The BECARE (GEM-2002) trial.

Citación estilo Chicago

Sanchez Mauriño, Pedro, Juan Jose Serrano Domingo, Regina García Galindo , Silvia Sequero-Lopez, Lourdes Gutierrez Sanz, AINARA SORIA RIVAS, y EVA MUÑOZ COUSELO. Real-life Evidence of Encorafenib Plus Binimetinib in Patients With Unresectable Advanced or Metastatic BRAFV600-mutant Melanoma in Spain: The BECARE (GEM-2002) Trial. 2025.

Cita MLA

Sanchez Mauriño, Pedro, et al. Real-life Evidence of Encorafenib Plus Binimetinib in Patients With Unresectable Advanced or Metastatic BRAFV600-mutant Melanoma in Spain: The BECARE (GEM-2002) Trial. 2025.